Myocardial hypertrophy and dysfunction in maternal diabetes.

Area of Science:

• Cardiology
• Maternal-Fetal Medicine
• Neonatology

Background:

• Diabetes in pregnancy (pre-gestational and gestational) is a significant risk factor for fetal myocardial hypertrophy, often linked to fetal hyperinsulinism.
• Fetal myocardial hypertrophy can lead to impaired cardiac function, particularly diastolic dysfunction, characterized by reduced left ventricular distensibility and altered left atrial dynamics.
• While neonatal myocardial hypertrophy typically regresses spontaneously, it can manifest as cardiomegaly and respiratory distress due to poor left ventricular compliance.

Purpose of the Study:

• To highlight the research priority in assessing diastolic function in fetuses of diabetic mothers, especially those with myocardial hypertrophy.
• To introduce novel echocardiographic parameters derived from the pathophysiological consequences of myocardial hypertrophy.
• To propose a scoring system for grading the severity of fetal diastolic dysfunction in this population.

Main Methods:

• Review and discussion of new echocardiographic parameters.
• Focus on parameters reflecting pathophysiological consequences of myocardial hypertrophy.
• Development of a grading score for fetal diastolic dysfunction.

Main Results:

• New echocardiographic parameters have been developed to assess diastolic function in fetuses of diabetic mothers.
• These parameters are based on the understanding of myocardial hypertrophy's impact on cardiac mechanics.
• A proposed score aims to quantify the severity of fetal diastolic dysfunction.

Conclusions:

• Assessment of diastolic function is a critical research area in fetuses affected by maternal diabetes and myocardial hypertrophy.
• Novel echocardiographic techniques offer promising tools for evaluating fetal cardiac health in diabetic pregnancies.
• A standardized scoring system could improve the clinical management and understanding of fetal diastolic dysfunction.